<DOC>
	<DOCNO>NCT01117142</DOCNO>
	<brief_summary>Background : - Chronic lymphocytic leukemia ( CLL ) , small lymphocytic lymphoma ( SLL ) , mantle cell lymphoma ( MCL ) type cancer many abnormal lymphocyte ( type white blood cell ) . Monoclonal B-cell lymphocytosis ( MBL ) condition individual large normal number lymphocyte . Individuals CLL , SLL , MBL , MCL may survive many year without need treatment , apparent correlation cell birth rate disease activity . By study birth death rate lymphocytes , researcher hope identify individual risk worsen disease . - Heavy water similar structure regular water , two deuterium atom instead two hydrogen atom . Deuterium one neutron hydrogen , make heavy water heavy . Heavy water radioactive , look taste like regular water , know harmful effect research-level dos . When small amount heavy water consume daily , newly produce blood cell label ( tag ) , allow researcher track cell growth measure birth death rate CLL , SLL , MBL , MCL normal lymphocyte . Objectives : - To study birth death rate lymphocytes individual MBL , CLL/SLL , MCL , compare lymphocytes healthy volunteer . Eligibility : - Individuals least 18 year age diagnose MBL , CLL , SLL , MCL , take certain agent ( Viagra , Levitra , Cialis , PDE-inhibitors , prednisone , cyclosporin-A , rapamycin , immunosuppressive agent , 2 cup green tea daily , Celebrex ) 4 week prior enrollment study . - Healthy volunteer least 18 year age , take certain agent ( Viagra , Levitra , Cialis , PDE-inhibitors , prednisone , cyclosporin-A , rapamycin , immunosuppressive agent , 2 cup green tea daily , Celebrex ) 4 week prior enrollment study . Design : - Participants screen medical history , physical examination , initial blood test . Other test may administer individual cancer , require study researcher . - All participant drink regular dos heavy water daily total 4 week ( label period ) . There optional 6-month follow-up wash-out period additional heavy water consume . - Blood sample collect weekly labeling period , bone marrow biopsy obtain possible . Individuals cancer may also lymph node biopsy part study . - Additional blood sample may collect optional wash-out phase study determine rate cancer cell disappear . - Treatment provide part protocol .</brief_summary>
	<brief_title>A Study Kinetics Lymphoid Cells Patients With Monoclonal B-cell Lymphocytosis ( MBL ) , Chronic Lymphocytic Leukemia ( CLL ) Small Lymphocytic Lymphoma ( SLL ) , Mantle Cell Lymphoma ( MCL ) Healthy Volunteers</brief_title>
	<detailed_description>Chronic lymphocytic leukemia ( CLL ) lymphoma variant , small lymphocytic lymphoma ( SLL ) decade consider disease cause progressive accumulation abnormal lymphocyte . The prevail view CLL SLL disease process driven underlying defect apoptosis . While resistance apoptosis appear important CLL SLL disease process , recent study suggest cellular proliferation important previously realize . Cells individual CLL drank deuterated water ( heavy water ) 6 week show turnover rate 0.1 % 1.1 % per day . In second study involve CLL subject drink heavy water , average CLL turnover rate similar range approximately 2-fold low average B-cell turnover rate healthy individual . These study show safety scientific value use heavy water study kinetics cell proliferation patient normal volunteer . We propose study expand finding investigator . This study address site proliferation CLL/SLL cell include individual monoclonal B-cell lymphocytosis ( MBL ) , possible precursor CLL . Furthermore , include patient mantle cell lymphoma ( MCL ) , disease tumor proliferation play important role . Study participant drink heavy water daily total 4 week ( label period ) optional 6 month follow ( wash period ) . Blood sample obtain weekly labeling period . A bone marrow and/or lymph node biopsy obtain possible labeling period . Additional blood draw may obtain optional wash-out phase study determine rate tumor cell disappear . The primary objective exploratory study obtain estimate proliferation rate tumor cell individual MBL , CLL/SLL , MCL . The secondary objective compare proliferation rate different anatomic compartment , specifically peripheral blood , lymph node , bone marrow estimation attrition disappearance rate cell optional phase protocol . Healthy volunteer may include comparison .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Lymphocytosis</mesh_term>
	<criteria>INCLUSION CRITERIA : ( MBL , CLL/SLL , MCL group ) 4.1.1. &lt; TAB &gt; Diagnosed MBL , CLL/SLL , MCL 4.1.2. &lt; TAB &gt; Greater equal 18 year age 4.1.3. &lt; TAB &gt; Neutrophil count ( ANC ) great equal 1000/mcL 4.1.4. &lt; TAB &gt; Platelet count great equal 50K/mcL EXCLUSION CRITERIA : ( MBL , CLL/SLL , MCL group ) 4.2.1. &lt; TAB &gt; Concomitant use agent describe affect biology and/or proliferation rate CLL cell approve accepted therapy CLL , SLL , MCL , MBL PDEinhibitors ( e.g . sildenafil , theophylline ) Immunosuppressive agent ( e.g. , prednisone , cyclosporinA , rapamycin ) Green Tea extract ( 2 cup per day ) Cox2 inhibitor 4.2.2. &lt; TAB &gt; Chronic current clinically significant infection , include HIV uncontrolled infection 4.2.3. &lt; TAB &gt; Receiving concurrent anticancer therapies 4.2.4. &lt; TAB &gt; Women pregnant nursing , well woman childbearing potential unwilling use agree upon form contraception duration participation study 4.2.5 &lt; TAB &gt; Sexually active male unwilling follow strict contraception requirement describe protocol . 4.2.6 &lt; TAB &gt; Inability understand investigational nature study , inability provide inform consent INCLUSION CRITERIA : ( Healthy volunteer group ) 4.3.1 &lt; TAB &gt; Health status confirm brief History Physical Exam blood work 4.3.2 &lt; TAB &gt; Greater equal 18 year age 4.3.3 &lt; TAB &gt; CBC coagulation panel within expect normal range subject EXCLUSION CRITERIA : ( Healthy volunteer group ) 4.4.1. &lt; TAB &gt; Concomitant use agent describe affect biology and/or proliferation rate CLL cell PDEinhibitors ( e.g . , slidenafil , theophylline ) Immunosuppressive agent ( e.g. , cyclosporinA , rapamycin ) Green Tea extract ( 2 cup per day ) Cox2 inhibitor &lt; TAB &gt; 4.4.2. &lt; TAB &gt; Women pregnant nursing , well woman childbearing potential unwilling use agree upon form contraception duration study participation . 4.4.3 &lt; TAB &gt; Sexually active male unwilling follow strict contraception requirement describe protocol . 4.4.4. &lt; TAB &gt; Inability understand investigational nature study , inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 19, 2016</verification_date>
	<keyword>CLL</keyword>
	<keyword>MBL</keyword>
	<keyword>SLL</keyword>
	<keyword>MCL</keyword>
	<keyword>Growth</keyword>
	<keyword>Development</keyword>
	<keyword>Aging</keyword>
	<keyword>Chronic Lymphocytic Leukemia</keyword>
	<keyword>Monoclonal B-Cell Lymphocytosis</keyword>
	<keyword>Small Lymphocytic Lymphoma</keyword>
	<keyword>Mantle Cell Lymphoma</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>